News Sentiment

RCKT sentiment intelligence

Rocket Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 48 Balanced news tone 63 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 3.44 Week of 17 Jul 2026
Weighted tone 48/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

81/100 classification confidence.

Company focus 54

directly relevant articles

Source quality 5

high-authority source matches

Trend context Trend inactive

-12.0% over one week, +2.7% over four weeks, trend inactive, and below fair value.

Latest direct headline Positive

Rocket Pharmaceuticals stock steadies as gene therapy pipeline advances and cash runway extends

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 81/100 classification
One-week reaction -12.0% Price reacting lower
Trend fit Trend inactive 2.7% over four weeks
Fair value -72.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 8
Neutral 46
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 54
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
TradingView 14
Market source 13
Stock Titan 12
simplywall.st 5
The National Law Review 3
www.marketscreener.com 3
MT Newswires 2
Ad-hoc-news.de 1

Event Lens

What the news is about

Classified themes
Market update 36
Earnings 15
Regulatory and legal 6
Analyst action 3
Deals and strategy 2
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 63
TradingView Direct company coverage

Price to sales forward of Rocket Pharmaceuticals, Inc. – NASDAQ:RCKT

This article provides the "Price to sales forward" metric for Rocket Pharmaceuticals, Inc. (RCKT) on the Nasdaq Stock Market. It is a financial data point presented by TradingView, with data sourced from ICE Data Services and FactSet. The page indicates that the market was closed

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 13:09
Source
TradingView
TradingView Direct company coverage

Rocket Pharmaceuticals, Inc. Actuals & Estimates (TRADEGATE:9IP1)

This article provides an overview of Rocket Pharmaceuticals, Inc. (TRADEGATE:9IP1) financial actuals and analyst estimates. It includes details on income statements, balance sheets, cash flow, and valuation metrics, along with FAQs about its stock ticker, forecasts, historical pr

Tone
Neutral 50/100
Event
Analyst action
Published
26 Jun 2026 02:40
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of Rocket Pharmaceuticals, Inc. – NASDAQ:RCKT

This article focuses on the enterprise value to revenue forward metric for Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT). It appears to be a stub or data-oriented piece from TradingView, indicating financial analysis for the biotechnology company. The content primarily lists naviga

Tone
Neutral 50/100
Event
Earnings
Published
25 Jun 2026 23:09
Source
TradingView